Capital Fund Management S.A. Makes New Investment in MKS Inc. $MKSI

Capital Fund Management S.A. bought a new stake in shares of MKS Inc. (NASDAQ:MKSIFree Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 16,915 shares of the scientific and technical instruments company’s stock, valued at approximately $1,681,000.

A number of other hedge funds also recently made changes to their positions in the business. Bayforest Capital Ltd bought a new position in MKS during the second quarter valued at about $39,000. Steph & Co. purchased a new position in MKS in the second quarter valued at about $42,000. Atlantic Union Bankshares Corp purchased a new position in MKS in the second quarter valued at about $46,000. Optimum Investment Advisors grew its position in shares of MKS by 25.0% during the 2nd quarter. Optimum Investment Advisors now owns 625 shares of the scientific and technical instruments company’s stock valued at $62,000 after acquiring an additional 125 shares during the period. Finally, Brooklyn Investment Group increased its stake in shares of MKS by 1,168.3% during the 1st quarter. Brooklyn Investment Group now owns 799 shares of the scientific and technical instruments company’s stock worth $64,000 after purchasing an additional 736 shares during the last quarter. 99.79% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other MKS news, Director Elizabeth Mora sold 300 shares of the firm’s stock in a transaction on Tuesday, December 2nd. The shares were sold at an average price of $158.81, for a total value of $47,643.00. Following the completion of the transaction, the director directly owned 18,963 shares of the company’s stock, valued at $3,011,514.03. This trade represents a 1.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jacqueline F. Moloney sold 300 shares of the business’s stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $122.14, for a total transaction of $36,642.00. Following the transaction, the director owned 11,562 shares of the company’s stock, valued at $1,412,182.68. This trade represents a 2.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 5,600 shares of company stock worth $734,285 in the last three months. 0.57% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on MKSI shares. The Goldman Sachs Group upped their price objective on MKS from $92.00 to $125.00 and gave the company a “sell” rating in a research note on Thursday, October 9th. Benchmark boosted their target price on MKS from $135.00 to $180.00 and gave the company a “buy” rating in a research note on Friday, November 7th. Wells Fargo & Company increased their price target on MKS from $135.00 to $150.00 and gave the stock an “equal weight” rating in a research note on Friday, November 7th. KeyCorp lifted their price objective on MKS from $160.00 to $180.00 and gave the stock an “overweight” rating in a report on Friday, November 7th. Finally, Deutsche Bank Aktiengesellschaft set a $175.00 price objective on shares of MKS and gave the company a “buy” rating in a report on Friday, October 31st. Nine research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, MKS presently has a consensus rating of “Moderate Buy” and a consensus price target of $159.64.

Read Our Latest Research Report on MKSI

MKS Stock Performance

NASDAQ:MKSI opened at $163.35 on Friday. The company has a debt-to-equity ratio of 1.64, a quick ratio of 1.81 and a current ratio of 2.86. MKS Inc. has a 52-week low of $54.84 and a 52-week high of $164.79. The firm has a market cap of $10.97 billion, a price-to-earnings ratio of 39.65, a PEG ratio of 1.75 and a beta of 1.93. The business’s fifty day moving average is $142.30 and its 200 day moving average is $115.12.

MKS (NASDAQ:MKSIGet Free Report) last issued its earnings results on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.80 by $0.13. MKS had a return on equity of 20.80% and a net margin of 7.25%.The business had revenue of $988.00 million during the quarter, compared to the consensus estimate of $963.87 million. During the same quarter last year, the company earned $1.72 EPS. The firm’s revenue was up 10.3% compared to the same quarter last year. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. Research analysts predict that MKS Inc. will post 6.94 EPS for the current year.

MKS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Investors of record on Monday, November 24th will be issued a dividend of $0.22 per share. This represents a $0.88 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Monday, November 24th. MKS’s dividend payout ratio is 21.36%.

MKS Profile

(Free Report)

MKS Instruments, Inc provides foundational technology solutions to semiconductor manufacturing, electronics and packaging, and specialty industrial applications in the United States, Germany, China, South Korea, and internationally. It operates through Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Material Solutions Division (MSD) segments.

Featured Articles

Want to see what other hedge funds are holding MKSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MKS Inc. (NASDAQ:MKSIFree Report).

Institutional Ownership by Quarter for MKS (NASDAQ:MKSI)

Receive News & Ratings for MKS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS and related companies with MarketBeat.com's FREE daily email newsletter.